Summary
To identify polypeptide growth factors for human teratocarcinoma cells, we studied the malignant ovarian teratoma-derived cell line, PA-1, that grew autonomously in serum-free medium. Medium conditioned by undifferentiated PA-1 cells strongly stimulated proliferation of the mouse mammary tumor cell line, GR 2H6, which is responsive to epidermal growth factor (EGF) and insulinlike growth factor-I (IGF-I). After ammonium sulfate precipitation, PA-1 conditioned medium was analyzed by anion exchange chromatography and bioassay of elution fractions on GR 2H6 cells that were grown in medium deficient in either EGF or insulin. The results demonstrated that PA-1 CM contained factors that can substitute for EGF and IGF-I in stimulating growth of GR 2H6 cells. Western blots of peak mitogenic fractions revealed low molecular weight polypeptides that were immunoreactive with either anti-EGF or anti-IGF-I antibodies. Indirect immunofluorescence staining of PA-1 cells with monoclonal antibodies localized receptors for each growth factor, and binding of human EGF and IGF-I to these cells was quantified by radioreceptor assays. Secretion of factors closely related to EGF and IGF-I by PA-1 cells under serum-free conditions may provide a novel model system to study molecular mechanisms of autocrine growth stimulation in teratocarcinomas.
Similar content being viewed by others
References
Adamson, E. D.; Meek, J. The ontogeny of epidermal growth factor receptors during mouse development. Dev. Biol. 103:62–70; 1984.
Betsholtz, C.; Westermark, B.; Ek, B., et al. Coexpression of a PDGF-like growth factor and PDGF receptors in a human osteosarcoma cell line: implications for autocrine receptor activation. Cell 39:447–457; 1984.
Braunhut, S. J.; Gudas, L. J.; Kurokawa, T., et al. Expression of fibroblast growth factor by F9 teratocarcinoma cells as a function of differentiation. J. Cell Biol. 108:2467–2476; 1989.
Campisi, J.; Gray, H. E.; Pardee, A. B., et al. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell 36:241–247; 1984.
Carlin, C. R.; Andrews, P. W. Human embryonal carcinoma cells express low levels of functional receptor for epidermal growth factor. Exp. Cell Res. 159:17–26; 1985.
Ciccodicola, A.; Dono, R.; Obici, S., et al. Molecular characterization of a gene of the ‘EGF family’ expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J. 8:1987–1991; 1989.
Han, V. K. M.; D’Ercole, A. J.; Lund, P. K. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236:193–197; 1987.
Heath, J. K.; Deller, M. J. Serum-free culture of PC13 murine embryonal carcinoma cells. J. Cell. Physiol. 115:225–230; 1983.
Heath, J. K.; Paterno, G. D.; Lindon, A. C., et al. Expression of multiple heparin-binding growth factor species by murine embryonal carcinoma and embryonic stem cells. Development 107:113–122; 1989.
Heath, J. K.; Shi, W. K. Developmentally regulated expression of insulin-like growth factors by differentiated murine teratocarcinomas and extraembryonic mesoderm. J. Embryol. Exp. Morphol. 95:193–212; 1986.
Hinegardner, R. T. An improved fluorometric assay for DNA. Anal. Biochem. 39:197–201; 1971.
Kawata, M.; Sekiya, S.; Hatakeyama, R., et al. Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma. Gynecol. Oncol. 32:191–197; 1989.
Keating, M. T.; Williams, L. T. Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. Science 239:914–916; 1988.
Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685; 1970.
Lang, R. A.; Burgess, A. W. Autocrine growth factors and tumourigenic transformation. Immunol. Today 11:244–249; 1990.
Leof, E. B.; Wharton, W.; Van Wyk, J. J., et al. Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells. Exp. Cell Res. 141:107–115; 1982.
Lund, P. K.; Moats-Staats, B. M.; Hynes, M. A., et al. Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissue. J. Biol. Chem. 261:14539–14544; 1986.
Marquardt, H.; Hunkapiller, M. W.; Hood, L. E., et al. Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science 223:1079–1082; 1984.
Martin, G. R. Teratocarcinomas and mammalian embryogenesis. Science 209:768–776; 1980.
Martin, G. R.; Evans, M. J. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodiesin vitro. Proc. Natl. Acad. Sci. USA 72:1441–1445; 1975.
Martin, G. R.; Smith, S.; Epstein, C. J. Protein synthetic patterns in teratocarcinoma stem cells and mouse embryos at early stages of development. Dev. Biol. 66:8–16; 1978.
Mercola, M.; Stiles, C. D. Growth factor superfamilies and mammalian embryogenesis. Development 102:451–460; 1988.
Mintz, B.; Illmensee, K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 72:3585–3589; 1975.
Murthy, U.; Basu, M.; Sen-Majumdar, A., et al. Perinuclear location and recycling of epidermal growth factor receptor kinase: immunofluorescence visualization using antibodies directed to kinase and extracellular domains. J. Cell Biol. 103:333–342; 1986.
Nagarajan, L.; Anderson, W. B.; Nissley, S. P., et al. Production of insulin-like growth factor-II (MSA) by endoderm-like cells derived from embryonal carcinoma cells: possible mediator of embryonic cell growth. J. Cell. Physiol. 124:199–206; 1985.
Nexo, E.; Hollenberg, M. D.; Figueroa, A., et al. Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development. Proc. Natl. Acad. Sci. USA 77:2782–2785; 1980.
Nicolas, J. F.; Avner, P.; Gaillard, J., et al. Cell lines derived from teratocarcinomas. Cancer Res. 36:4224–4231; 1976.
Popliker, M.; Shatz, A.; Avivi, A., et al. Onset of endogenous synthesis of epidermal growth factor in neonatal mice. Dev. Biol. 119:38–44; 1987.
Rao, L. V.; Wikarczuk, M. L.; Heyner, S. Functional roles of insulin and insulinlike growth factors in preimplantation mouse embryo development. In Vitro Cell. Dev. Biol. 26:1043–1048; 1990.
Rees, A. R.; Adamson, E. D.; Graham, C. F. Epidermal growth factor receptors increase during the differentiation of embryonal carcinoma cells. Nature 281:309–311; 1979.
Rizzino, A.; Crowley, C. Growth and differentiation of embryonal carcinoma cell line F9 in defined medium. Proc. Natl. Acad. Sci. USA 77:457–461; 1980.
Rizzino, A.; Kuszynski, C.; Ruff, E., et al. Production and utilization of growth factors related to fibroblast growth factor by embryonal carcinoma cells and their differentiated cells. Dev. Biol. 129:61–71; 1988.
Rotwein, P.; Burgess, S. K.; Milbrandt, J. D., et al. Differential expression of insulin-like growth factor genes in rat central nervous system. Proc. Natl. Acad. Sci. USA 85:265–269; 1988.
Sara, V. R.; Carlsson-Skwirut, C.; Andersson, C., et al. Characterization of somatomedins from fetal brain: identification of a variant form of insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 83:4904–4907; 1986.
Smith, E. P.; Sadler, T. W.; D’Ercole, A. J. Somatomedins/insulin-like growth factors, their receptors and binding proteins are present during mouse embryogenesis. Development 101:73–82; 1987.
Sporn, M. B.; Roberts, A. B. Autocrine growth factors and cancer. Nature 313:745–747; 1985.
Tainsky, M. A.; Cooper, C. S.; Giovanella, B. C., et al. An activatedras N gene: detected in late but not early passage human PA1 teratocarcinoma cells. Science 225:643–645; 1984.
Tainsky, M. A.; Shamanski, F.; Blair, D., et al. Causal role for an activated N-ras oncogene in the induction of tumorigenicity acquired by a human cell line. Cancer Res. 47:3235–3238; 1987.
Tomooka, Y.; Kawakatsu, H.; Jing, N., et al. Tenascin production and characterization of newly cloned cell lines from GR and C3H mouse mammary tumors. Nagoya, Japan: Proceedings of the Japanese Cancer Association; 1989:160.
Towbin, H.; Staehelin, T.; Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350–4354; 1979.
Van Zoelen, E. J. J.; Ward-Van Oostwaard, T. M. J.; Nieuwland, R., et al. Identification and characterization of polypeptide growth factors secreted by murine embryonal carcinoma cells. Dev. Biol. 133:272–283; 1989.
Weima, S. M.; Stet, L. H.; Van Rooijen, M. A., et al. Human teratocarcinoma cells express functional insulin-like growth factor I receptors. Exp. Cell Res. 184:427–439; 1989.
Weller, A.; Meek, J.; Adamson, E. D. Preparation and properties of monoclonal and polyclonal antibodies to mouse epidermal growth factor (EGF) receptors: evidence for cryptic EGF receptors in embryonal carcinoma cells. Development 100:351–363; 1987.
Zeuthen, J.; Norgaard, J. O. R.; Avner, P., et al. Characterization of a human ovarian teratocarcinoma-derived cell line. Int. J. Cancer 25:19–32; 1980.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jing, N., Shiurba, R., Kitani, H. et al. Secretion of polypeptides related to epidermal growth factor and insulinlike growth factor I by a human teratocarcinoma cell line. In Vitro Cell Dev Biol - Animal 27, 864–872 (1991). https://doi.org/10.1007/BF02630989
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02630989